The Quantum Capital Partners GmbH, an international investment company based in Munich, has sold all shares of mdexx GmbH, based in Weyhe, to Zhuzhou Lince Group Co. Limited (Lince). The purchase price has been kept confidential.

After successful realignment and sustainable return of mdexx to profitability, Lince was found to be the ideal strategic partner for the future development of mdexx. For Quantum, the sale of mdexx marks a successful exit from the first fund launched in 2014.

TRACC Legal, led by Dr. Thomas Lotz, advised Quantum in this transaction. Rödl & Partner, led by Klaus Martin Haussmann, supported this transaction on the buyer Lince's side.

About the mdexx Group

The mdexx Group develops and produces transformers, power supplies, chokes and filters, as well as axial and radial fans, especially for the railway sector but also for the medical technology sector. Around 500 employees work at the locations in Weyhe (Germany), Trutnov (Czech Republic), and Tianjin (China).

About Quantum Capital Partners

Quantum Capital Partners focuses on companies with significant growth potential, aiming to provide them with a profitable future and sustainable growth. The first fund was launched in 2014. The mdexx Group has been part of the portfolio since 2016.

About the Lince Group

Founded in 1979, Lince is headquartered in Zhuzhou, Hunan Province, China. Lince is a supplier to the railway sector and produces, among other things, braking systems and fans. With around 4,000 employees, it generated approximately EUR 450 million in revenue in 2016. The acquisition of the mdexx Group enables Lince to enter the European market. At the same time, the mdexx Group gains a stronger position in the Chinese market through the strategic investor.

Contact Person:

Tilman Richter, Director
Phone: +49 89 45 213 29 12
Email: t.richter@quantum-capital-partners.com